74 F
Belize City
Sunday, October 24, 2021
Home Highlights Blood pressure/heart meds recalled due to health risks

Blood pressure/heart meds recalled due to health risks

SourceDayne Guy

BELMOPAN, Wed. Oct. 6, 2021– The Ministry of Health and Wellness this week received a letter from the pharmaceutical company Denk Pharma GMBH & Co. KG, which advised the Ministry to conduct a voluntary recall of Losar-Denk (Losartan) and CoLosar-Denk (Losartan/Hydrochlorothiazide) medications from the Belizean market.

The medications are generally used to treat high blood pressure and heart failure, but European health authorities identified traces of a possible carcinogenic impurity “4-Chlor-Azidomethyltetrazole” within the active ingredient in the medication, Losartan — thus prompting the recommendation for a recall of the meds.

An AMES test (a mutagenicity test) that was conducted on the pills had yielded a positive result — indicating the presence of the impurity, which is a genotoxic substance. There currently is no clinical data on the impact of the impurity on humans, but based on investigations conducted by the Denk Pharma GmbH & Co. KG, the voluntary recall was deemed to be the best course of action.

European authorities have stated that the impurity was formed in the production of Losartan and is associated with the active ingredient of at least three manufacturers. The concentration of the impurity exceeded the Threshold of Toxicological Concern (TTC) limit. Based on TTC guidelines, it was recommended that products containing this genotoxic be recalled to limit carcinogenic risk.

Guided by this recommendation, the Health Ministry is encouraging the public to discontinue use of the listed medications and to discard those meds or return them to the nearest pharmacy. In Belize, the only importer registered to import from the Denk manufacturer is James Brodie & Co. Ltd. The company issued a release which stated, “Customers should return the following medications in their box to any of our pharmacies, where a voucher will be given in return.”

Denk Pharma has committed to covering the entirety of the costs relating to the recall, including the costs of destruction and the value of the goods. As a result, James Brodie and Co. Ltd. urges affected persons to provide information at the soonest convenience, but before the end of 2021 to allow for a credit note to be filed.

The Denk Pharma GmbH & Co. KG is yet to receive official reports of adverse events associated with the impurity. The German Federal Institute for Drugs and Medical Devices (BfArM), however, mentioned that preliminary assessments indicate a significantly lower health risk as opposed to nitrosamines. According to Denk Pharma GmbH & Co. KG, the available data suggests that the risks of untreated cardiovascular disease may outweigh the potential risks of this impurity.

- Advertisment -

Most Popular

Barbados elects first ever president ahead of becoming republic

Barbados has elected its first ever president as it prepares to become a republic, removing Queen Elizabeth as head of state. Dame Sandra Mason, 72,...

UDP calls for Police Minister and CEO to resign

BELMOPAN, Tues. Oct.19, 2021-- The Secretariat of the United Democratic Party (UDP) issued a press release this week in which it condemns the Minister...

Proper police training

Dear Editor, Police abuse and brutality continue to plague our jewel Belize unabated. The incident in Cayo of law enforcement officers using brute force and...

Belize gets rough initiation into international Rugby

BELIZE CITY, Wed. Oct. 20, 2021-- Commenting on a breakingbelizenews.com report by Ruben Morales Iglesias on Monday of this week, English pioneer of rugby...